MXPA03003820A - Derivados de benzoxazinona, su preparacion y uso. - Google Patents

Derivados de benzoxazinona, su preparacion y uso.

Info

Publication number
MXPA03003820A
MXPA03003820A MXPA03003820A MXPA03003820A MXPA03003820A MX PA03003820 A MXPA03003820 A MX PA03003820A MX PA03003820 A MXPA03003820 A MX PA03003820A MX PA03003820 A MXPA03003820 A MX PA03003820A MX PA03003820 A MXPA03003820 A MX PA03003820A
Authority
MX
Mexico
Prior art keywords
preparation
benzoxazinone derivatives
benzoxazinone
derivatives
Prior art date
Application number
MXPA03003820A
Other languages
English (en)
Inventor
Mervyn Thompson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026224A external-priority patent/GB0026224D0/en
Priority claimed from GB0111858A external-priority patent/GB0111858D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MXPA03003820A publication Critical patent/MXPA03003820A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MXPA03003820A 2000-10-26 2001-10-22 Derivados de benzoxazinona, su preparacion y uso. MXPA03003820A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0026224A GB0026224D0 (en) 2000-10-26 2000-10-26 Novel compounds
GB0111858A GB0111858D0 (en) 2001-05-15 2001-05-15 Novel compounds
PCT/EP2001/012344 WO2002034754A2 (en) 2000-10-26 2001-10-22 Benzoxazinone derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
MXPA03003820A true MXPA03003820A (es) 2003-07-28

Family

ID=26245199

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003820A MXPA03003820A (es) 2000-10-26 2001-10-22 Derivados de benzoxazinona, su preparacion y uso.

Country Status (20)

Country Link
US (1) US6939871B2 (es)
EP (1) EP1330460B1 (es)
JP (1) JP4242643B2 (es)
KR (1) KR20030051747A (es)
CN (1) CN1478092A (es)
AR (1) AR034174A1 (es)
AT (1) ATE357448T1 (es)
AU (1) AU2002224791A1 (es)
BR (1) BR0114881A (es)
CA (1) CA2426706A1 (es)
CZ (1) CZ20031163A3 (es)
DE (1) DE60127434T2 (es)
ES (1) ES2280417T3 (es)
HU (1) HUP0301458A2 (es)
IL (1) IL155520A0 (es)
MX (1) MXPA03003820A (es)
NO (1) NO20031838L (es)
PL (1) PL366378A1 (es)
TW (1) TWI237023B (es)
WO (1) WO2002034754A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203811D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203778D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203804D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
AU2003260882A1 (en) * 2002-09-26 2004-04-19 Warner-Lambert Company Llc Heterocyclic substituted piperazines for the treatment of schizophrenia
ATE463494T1 (de) 2002-10-10 2010-04-15 Morphochem Ag Komb Chemie Neue verbindungen mit antibakterieller aktivität
EP1562918B1 (en) 2002-11-08 2008-01-16 F. Hoffmann-La Roche Ag Substituted benzoxazinones and uses thereof
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
BRPI0409684A (pt) * 2003-04-30 2006-04-18 Fmc Corp derivados de dihidrobenzofurano e dihidrobenzopirano (dihalopropenil) fenilalquila substituìdos inseticidas
GB0310851D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0310849D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
RU2007107177A (ru) * 2004-07-28 2008-09-10 Айрм Ллк (Bm) Соединения и композиции, как модуляторы ядерных рецепторов стероидных гормонов
CA2625687A1 (en) * 2005-10-13 2007-04-19 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Antibacterial active 5-chinolin derivative
CN102361863B (zh) 2009-01-21 2014-12-03 巴斯利尔药物股份公司 新的二环抗生素
SI2513115T1 (sl) 2009-12-18 2014-02-28 Basilea Pharmaceutica Ag Triciklični antibiotiki
ES2596369T3 (es) 2011-06-17 2017-01-09 Basilea Pharmaceutica Ag Antibióticos N-heterotricíclicos
PL3448859T3 (pl) 2017-03-20 2020-02-28 Forma Therapeutics, Inc. Kompozycje pirolopirolu jako aktywatory kinazy pirogronianowej (PKR)
JP7450610B2 (ja) 2018-09-19 2024-03-15 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー ピルビン酸キナーゼｒの活性化
US20200129485A1 (en) 2018-09-19 2020-04-30 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU731104B2 (en) * 1996-05-29 2001-03-22 Warner-Lambert Company Benzoxazinone dopamine D4 receptor antagonists
EP0900792B1 (en) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
AU2494300A (en) * 1999-01-07 2000-07-24 American Home Products Corporation 3,4-dihydro-2h-benzo(1,4)oxazine derivatives
TW546299B (en) * 1999-01-07 2003-08-11 Wyeth Corp 3,4-dihydro-2H-benzo[1,4]oxazinyl-methyl-[3-(1H-indol-3-yl)-alkyl]-amines

Also Published As

Publication number Publication date
JP4242643B2 (ja) 2009-03-25
DE60127434D1 (de) 2007-05-03
TWI237023B (en) 2005-08-01
EP1330460A2 (en) 2003-07-30
WO2002034754A2 (en) 2002-05-02
NO20031838D0 (no) 2003-04-24
CZ20031163A3 (cs) 2004-04-14
US6939871B2 (en) 2005-09-06
DE60127434T2 (de) 2007-11-29
ATE357448T1 (de) 2007-04-15
AU2002224791A1 (en) 2002-05-06
WO2002034754A3 (en) 2002-07-11
CA2426706A1 (en) 2002-05-02
KR20030051747A (ko) 2003-06-25
AR034174A1 (es) 2004-02-04
ES2280417T3 (es) 2007-09-16
CN1478092A (zh) 2004-02-25
IL155520A0 (en) 2003-11-23
HUP0301458A2 (hu) 2003-10-28
US20040063704A1 (en) 2004-04-01
BR0114881A (pt) 2003-09-30
PL366378A1 (en) 2005-01-24
JP2004516250A (ja) 2004-06-03
NO20031838L (no) 2003-06-24
EP1330460B1 (en) 2007-03-21

Similar Documents

Publication Publication Date Title
ZA200107983B (en) New compounds, their preparation and use.
HK1061679A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
HK1053118A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof.
HUP0301243A3 (en) Herbicidal substituted pyridine-ketones, preparation and use thereof
MXPA03003820A (es) Derivados de benzoxazinona, su preparacion y uso.
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
MXPA02005950A (es) Silla.
MXPA03004593A (es) Derivados de naftaleno.
HK1048999A1 (zh) 氮雜䓬吲衍生物，它們的製備和應用
AU2001248279A1 (en) New compounds, their preparation and use
HK1050004A1 (en) Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands.
AU2002359126A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
HUP0303291A3 (en) Herbicidal composition, preparation and use thereof
AU2002359123A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
ZA200204814B (en) Substituted phenyl-piperazine derivatives, their preparation and use.
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
AU2001264044A1 (en) 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
MXPA03000644A (es) Nuevos derivados de indol y uso como medicamentos.
HUP0303369A3 (en) Herbicidal composition, preparation and use thereof
ZA200205482B (en) Aminosulfonylbiphenyl derivatives.
HUP0204554A3 (en) Endoparasiticidal composition, preparation and use thereof
HK1050890A1 (en) Aminomethyl -phenyl-cyclohexanone derivatives.
MXPA03005622A (es) Tintes de antraquinona, preparacion de los mismos y uso de los mismos.